Watchlist Price Alert

Catalyst Pharmaceuticals ... (CPRX)

NASDAQ: CPRX · Real-Time Price · USD

23.34

-0.33 (-1.39%)

At close: Jun 17, 2025, 10:36 AM

Catalyst Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	517.55M	137.64M	298.39M	171.44M	130.24M	89.51M	16.56M	57.5M	13.89M
Short-Term Investments	n/a	n/a	n/a	19.82M	10.04M	5.01M	36.92M	26.52M	26.51M
Long-Term Investments	21.56M	16.49M	n/a	n/a	n/a	n/a	5.01M	n/a	n/a
Other Long-Term Assets	n/a	n/a	9K	9K	8.89K	8.89K	8.89K	8.89K	8.89K
Receivables	65.48M	53.51M	10.44M	6.62M	5.99M	10.54M	n/a	n/a	n/a
Inventory	19.54M	15.64M	6.8M	7.87M	4.65M	1.96M	56.01K	n/a	n/a
Other Current Assets	1.04M	489K	931K	432K	528.62K	4.35M	272.17K	58.28K	36.44K
Total Current Assets	623.61M	219.33M	320.8M	210.11M	159.24M	111.36M	55.19M	85.19M	41.45M
Property-Plant & Equipment	3.58M	3.7M	3.62M	3.98M	129.8K	1M	245.43K	191.38K	244.2K
Goodwill & Intangibles	156.67M	194.05M	32.47M	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	227.8M	250.78M	54.83M	27.68M	33.11M	1.01M	5.26M	200.27K	253.09K
Total Assets	851.41M	470.11M	375.63M	237.79M	192.35M	112.38M	60.45M	85.39M	41.71M
Account Payables	16.59M	14.79M	3.98M	2.77M	4.26M	4.12M	2.34M	1.95M	933.18K
Deferred Revenue	n/a	n/a	n/a	23.74M	18.36M	19.51M	33.41K	24.01K	18.09K
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	103.19M	51.29M	39.44M	19.87M	4.1M	15.08M	2.04M	1.5M	897.12K
Total Current Liabilities	120.68M	76.06M	57.59M	27.06M	22.76M	24.1M	9.51M	4.27M	2.09M
Long-Term Debt	2.79M	n/a	3.56M	3.89M	n/a	647.53K	n/a	n/a	n/a
Other Long-Term Liabilities	315K	2.98M	10.51M	-3.89M	n/a	-647.53K	154.8K	157.46K	303.39K
Total Long-Term Liabilities	3.1M	6.17M	17.62M	3.89M	n/a	647.53K	154.8K	157.46K	303.39K
Total Liabilities	123.78M	82.23M	75.21M	30.96M	22.76M	24.75M	9.67M	4.42M	2.4M
Total Debt	3.19M	3.56M	3.89M	3.89M	28.77K	647.53K	n/a	n/a	n/a
Common Stock	121K	107K	105K	103K	103.78K	103.4K	102.74K	102.55K	82.97K
Retained Earnings	285.16M	121.27M	49.86M	-26.31M	-53.71M	-128.69M	-160.56M	-126.56M	-108.15M
Comprehensive Income	64K	14K	24K	-148K	31.33K	9.51K	-20.25K	-159.17K	-113.48K
Shareholders Equity	727.63M	387.88M	300.42M	206.83M	169.6M	87.63M	50.78M	80.96M	39.31M
Total Investments	21.56M	16.49M	n/a	19.82M	10.04M	5.01M	41.93M	26.52M	26.51M